Singbao International Co Ltd Asset Resilience Ratio
Singbao International Co Ltd asset resilience ratio. Singbao International Co Ltd (6130) has an Asset Resilience Ratio of 2.76% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 6130 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Singbao International Co Ltd (2015–2025)
Asset resilience ratio of Singbao International Co Ltd from 2015 to 2025. This chart shows how Singbao International Co Ltd's Asset Resilience Ratio has changed over time. Read Singbao International Co Ltd total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Singbao International Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Singbao International Co Ltd total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$20.20 Million | 2.76% |
| Total Liquid Assets | NT$20.20 Million | 2.76% |
Asset Resilience Insights
- Limited Liquidity: Singbao International Co Ltd maintains only 2.76% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Singbao International Co Ltd Industry Peers by Asset Resilience Ratio
Compare Singbao International Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Merck & Company Inc
NYSE:MRK |
Drug Manufacturers - General | 0.22% |
|
AstraZeneca PLC
NASDAQ:AZN |
Drug Manufacturers - General | 0.10% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 5.33% |
|
Cosmo Pharmaceuticals N.V
F:C43 |
Drug Manufacturers - General | 10.92% |
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
|
Eli Lilly and Company
SA:LILY34 |
Drug Manufacturers - General | 6.46% |
|
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3 |
Drug Manufacturers - General | 6.34% |
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SHG:600436 |
Drug Manufacturers - General | 17.40% |
Singbao International Co Ltd Asset Resilience Ratio by Year (2015–2025)
Singbao International Co Ltd asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Singbao International Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.44% | NT$21.38 Million ≈ $673.65K |
NT$877.78 Million ≈ $27.65 Million |
+0.29pp |
| 2024-12-31 | 2.14% | NT$20.96 Million ≈ $660.32K |
NT$978.41 Million ≈ $30.83 Million |
-2.59pp |
| 2023-12-31 | 4.74% | NT$45.79 Million ≈ $1.44 Million |
NT$966.90 Million ≈ $30.46 Million |
+0.44pp |
| 2022-12-31 | 4.30% | NT$40.37 Million ≈ $1.27 Million |
NT$938.96 Million ≈ $29.58 Million |
+2.38pp |
| 2021-12-31 | 1.92% | NT$10.55 Million ≈ $332.29K |
NT$550.64 Million ≈ $17.35 Million |
+0.62pp |
| 2020-12-31 | 1.30% | NT$15.88 Million ≈ $500.34K |
NT$1.22 Billion ≈ $38.48 Million |
-0.70pp |
| 2019-12-31 | 2.00% | NT$11.22 Million ≈ $353.52K |
NT$562.21 Million ≈ $17.71 Million |
+0.13pp |
| 2018-12-31 | 1.86% | NT$7.68 Million ≈ $241.93K |
NT$412.31 Million ≈ $12.99 Million |
-2.18pp |
| 2017-12-31 | 4.04% | NT$17.86 Million ≈ $562.75K |
NT$442.18 Million ≈ $13.93 Million |
-11.85pp |
| 2016-12-31 | 15.89% | NT$50.00 Million ≈ $1.58 Million |
NT$314.67 Million ≈ $9.91 Million |
+0.97pp |
| 2015-12-31 | 14.92% | NT$50.00 Million ≈ $1.58 Million |
NT$335.07 Million ≈ $10.56 Million |
-- |
About Singbao International Co Ltd
Shangya Technology Co., Ltd. engages in the generic drugs and solar power generation businesses in Taiwan and Asia. The company wholesales Chinese and Western medicines, medical equipment, and beauty and hair care products; and onrito, lixin fumitation, lufuxing film-coated, amperex film coating, leverb-coated, triton film-coated, special core stabilized, tanlipo film-coated, inhibitory film-coat… Read more